Huawei Shows Signs of Strain From U.S. Pressure on Chips

China's Huawei is facing revenue pressure as the U.S. squeezes its chip supplies and an increasing number of countries shun its 5G gear. 


 
Walmart Sues U.S., Aiming to Head Off Opioid Penalties

Walmart sued the federal government in an attempt to strike a pre-emptive blow against what it said is an impending opioid-related civil lawsuit from the Justice Department. 


 
Uber and Lyft Must Classify Drivers as Employees, Appeals Court Says

The ride-hailing companies must comply with an order that requires them to reclassify their drivers as employees, a California appeals court said, siding with a lower-court ruling that threatened to upend the business models. 


 
Intel's Cloud Thickens

The chip maker's data-center sales slow just as it faces key questions about manufacturing outlook. 


 
FTC Staff Support Lawsuit Against Facebook

Federal Trade Commission staff members are recommending that the agency bring an antitrust case against Facebook, according to people familiar with the matter, but commissioners haven't reached a decision. 


 
French Court Asks Microsoft for Safeguards Against U.S. Surveillance of Health Data

A French court has ruled that Microsoft can continue hosting a government-run project aggregating citizens' anonymous health data, but must guarantee no data will be sent to the U.S. or be shared with American intelligence. 


 
Capital One Opens Wallet on Credit Performance

Capital One gave investors one of the most detailed pictures to date of what is happening to consumer debt. That should give investors some comfort about banks, though not as much about the consumer economy. 


 
Covid-19 Drug Remdesivir Fully Approved by FDA

The Food and Drug Administration has granted a full final approval to Gilead Sciences's remdesivir, making it the first Covid-19 treatment deemed safe and effective by the regulator. 


 
Gap's Story Looks Too Good to Be True

The retailer's plans for its portfolio of brands are promising but ambitious. 


 
California Loses Last-Ditch Effort to Force Exide to Deal With Toxic Legacy

California taxpayers were left responsible for a contaminated plant outside Los Angeles after a judge turned down an emergency bid by state environmental regulators to block Exide Technologies from exiting bankruptcy.

(END) Dow Jones Newswires

10-23-20 0915ET